Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,714 | 37,968 | 32,061 | 45,128 | 40,321 |
| Marketable Securities | 27,333 | 43,200 | 65,506 | 66,126 | 79,830 |
| Receivables | 1,080 | 834 | 588 | 430 | 16,387 |
| Other current assets | 849 | 1,458 | 1,831 | 2,456 | 2,412 |
| TOTAL | $71,976 | $83,460 | $99,986 | $114,140 | $138,950 |
| Non-Current Assets | |||||
| PPE Net | 7,940 | 8,445 | 8,906 | 9,461 | 10,002 |
| Intangibles | 0 | 4,671 | 4,671 | 4,671 | 4,671 |
| Other Non-Current Assets | 7,102 | 7,110 | 7,120 | 7,131 | 1,166 |
| TOTAL | $15,042 | $20,226 | $20,697 | $21,263 | $15,839 |
| Total Assets | $87,018 | $103,686 | $120,683 | $135,403 | $154,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 229 | 1,639 |
| Accounts payable and accrued liabilities | 2,589 | 2,393 | 2,307 | 2,217 | 3,424 |
| Accrued Expenses | 11,409 | 12,630 | 5,582 | 16,513 | 20,088 |
| Other current liabilities | 852 | 501 | 8,648 | 810 | 808 |
| TOTAL | $16,530 | $32,189 | $18,187 | $21,405 | $27,580 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,680 | 16,665 | 1,650 | 1,636 | 1,621 |
| Other Non-Current Liabilities | 12,329 | 13,638 | 13,177 | 14,489 | 15,897 |
| TOTAL | $18,142 | $19,874 | $34,837 | $36,572 | $38,389 |
| Total Liabilities | $34,672 | $52,063 | $53,024 | $57,977 | $65,969 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,589 | 53,506 | 53,506 | 53,389 | 53,350 |
| Common Shares | 53 | 53 | 3 | 53 | 53 |
| Retained earnings | -489,152 | -488,921 | -470,513 | -458,877 | -444,519 |
| Other shareholders' equity | 12 | 88 | 49 | 5 | -11 |
| TOTAL | $52,346 | $51,623 | $67,659 | $77,426 | $88,820 |
| Total Liabilities And Equity | $87,018 | $103,686 | $120,683 | $135,403 | $154,789 |